May 12, 2026 | 4 pm MT Makoto Tachibana, Ph.D. Professor, Osaka University
"Role of iron metabolism in mouse male sex determination"
|
| |
June 3, 2026 | 9 am MT Nunziata Maio, PhD Staff Scientist, NIH/NICHD
"Compartment-Specific Iron-Sulfur Cluster Assembly Defects: Clinical Consequences and Emerging Therapeutic Strategies"
|
| |
May 5, 2026 | 12 pm ET Marcin Wlodarski, MD, PhD Associate Member, Experimental Hematology, St. Jude Children's Research Hospital
"Genomic discoveries in bone marrow failure syndromes: from germline variants to somatic gene rescue"
|
| |
June 19, 2026 | 12 pm ET Alexander Gitlin, MD, PhD Assistant Professor, Immunology Program, Memorial Sloan Kettering Cancer Center
"Independent mechanisms of inflammation and myeloid bias in VEXAS Syndrome"
|
| |
The Hypoxia Core of the IU School of Medicine Cooperative Center of Excellence in Hematology (IU-CCEH) provides resources for members of the IU-CCEH center, other centers, and outside investigators in the area of nonmalignant hematology to generate information critical for better understanding cellular, molecular, and biochemical aspects of hematopoietic stem, progenitor, immune and stromal cells under relevant physiological conditions (i.e., lowered oxygen tension).
O2 tension within bone marrow (BM;1-5%) and cord blood (CB) or mobilized peripheral blood (mPB; <10%), is lower than in the ambient air (~21% O2) in which they are routinely collected for analysis. While it has been known for >40 years that HSC and HPC grow better ex-vivo in lowered (≤ 5%) O2, the core's report (Mantel, et. al., Cell, 2015) and more recent work demonstrate that collection/processing of BM, CB, and mPB in ambient air results in large decreases in phenotypically defined and functional HSC and increased HPC numbers within minutes of cell exposure to ambient air. The core termed this process Extra Physiological Shock/Stress (EPHOSS). Collection/processing of cells at 3% O2, such that they are never exposed to ambient air, resulted in two to five-fold increases in phenotypically- and functionally-detectable HSC. As well, this manifested as different gene expression patterns and responsiveness to stimuli associated with HSC. Similar changes were also noted with murine pre-leukemic and immune cells. Reevaluation of hematopoietic function associated with maintenance of HSC and HPC at lowered O2 levels can now be elucidated through the expertise of the Hypoxia Core. New data derived with the core's hypoxia chamber demonstrates the incredible power of the core to serve the hematopoietic community.
Specific aims of the Hypoxia Core involving normal and nonmalignant murine and human hematology are:
- Provide outstanding, consistent and timely analysis of mouse and human BM, mPB, immune and stromal cells, and human CB, BM, and mPB collected/processed at 3%, as well as other, O2 tensions compared to that in ambient air.
- Coordinate with the other IU-CCEH cores for in-depth analysis of cells collected in hypoxia vs. ambient air.
- Enhance productivity of IU-CCEH and other CCEH members, and outside investigators by providing a centralized set of services with reduced cost, and expert guidance not currently available elsewhere.
- Provide advice regarding intricacies of such studies, analyses, and overcoming potential problems. The core provides an economic resource that will add new and significant cutting-edge scientific analysis to greatly advance our current understanding of HSC/HPC and immune and stromal cell biology in ways that will increase their translational use for clinical benefit.
Services
- Expert guidance on designing experimental protocols.
- Options to have the core staff train individuals to use the equipment or have our trained staff perform the experiment.
- Access to an Agilent Seahorse machine under varying O2 and CO2 concentrations to examine cell metabolism under physiological conditions.
Visit them ▸
|
| |
|
|
Workshop on Molecular Aspects of Myeloid Stem Cell Development and Leukemia |
|
Cincinnati, OH | May 18 - 21, 2026 |
|
|
| |
|
|
European Hematology Association 2026 Congress |
|
Stockholm, Sweden | June 11 - 14, 2026 |
|
|
| |
|
|
Gordon Research Conference Integrative Mechanisms of Hemostasis in Health and Disease |
|
Waterville Valley, NH | August 2 - 7, 2026 |
|
|
| |
|
|
International Society for Experimental Hematology Annual Meeting |
|
Frankfurt, Germany | August 27 - 30, 2026 |
|
|
| |
|
|
East-West Iron Club Meeting |
|
Orlando, FL | October 22 - 23, 2026 |
|
|
| |
|
|
Summer Intern Programs at Fred Hutch! |
Seattle, WA | October 8 - 9, 2026
With summer just around the corner, campus will be energized with hundreds of summer interns from high schoolers to undergraduates (including high school teachers). Please see links for more information to share with colleagues, family and friends interested in applying in the future. |
|
|
| |
|
|
Postdoc Recruitment in Immunology, Medicine and Data Science (PRIMeD) |
Seattle, WA | October 8 - 9, 2026
Fred Hutch Cancer Center's Translational Data Science Integrated Research Center (TDS IRC) and Immunotherapy IRC invite PhD (or equivalent) students and recent graduates planning to begin a postdoctoral position by November 2027 to apply for Postdoc Recruitment in Immunology, Medicine and Data science (PRIMeD) at Fred Hutch Cancer Center in Seattle, Washington.
|
|
|
| |
Postdoctoral Associate Trowbridge Lab @ The Jackson Laboratory
|
| |
|
Dr. Kang is an Assistant Professor in the Division of Hematology at Washington University in St. Louis. Her lab studies cell fate decision and lineage specification mechanisms in the hematopoietic system. In particular, her group is interested in the signaling pathways and genetic networks that regulate hematopoietic stem cell and multipotent progenitor differentiation trajectories. The ultimate goal of her work is to modulate lineage trajectory to control blood cell output for therapeutic purposes in disease and aging contexts. Dr. Kang is the recent recipient of an American Cancer Society Research Scholar Grant, and received a CCEH P&F Type B Award in 2024. Dr. Kang is actively recruiting motivated and passionate postdocs, students, and research technicians to work with!
|
|
|
|
|
| |
Congratulations to Reuben Kapur for their recent publication
A function-first legacy in hematopoietic stem cell biology: the scientific impact of Hal E. Broxmeyer
Link to Publication ▸
|
| |
Congratulations to Iqbal Hamza for their recent publication
A cell-nonautonomous heme acquisition pathway enables erythroid hemoglobinization under stress
Link to Publication ▸
|
| |
Congratulations to Tina Termini for their recent publication
The bone marrow niche and hematopoietic system are distinctly remodeled by CD45-targeted astatine-211 radioimmunotherapy
Link to Publication ▸
|
| |
Congratulations to Paul Sigala for their recent publication
Acyl Carrier Protein is Essential for Apicoplast Biogenesis in Malaria Parasites Independent of Fatty Acid Synthesis
Link to Publication ▸
|
| |
Congratulations to Stephanie Hurwitz for their recent publication
Advanced deep learning enables prediction of allogeneic stem cell mobilization success
Link to Publication ▸
|
| |
Congratulations to Paul Sigala for their recent publication
Fifty shades of iron: Unorthodox mechanisms of iron acquisition and utilization in blood-stage Plasmodium parasites
Link to Publication ▸
|
| |
Congratulations to Hicks lab and Utah CIHD Protein-Metabolite Discovery Core, in collaboration with Kim Orth at UTSW for their recent publication
Inhibition of FicD-mediated AMPylation and deAMPylation by isoprenoid diphosphates
Link to Publication ▸
|
| |
Congratulations to Stephanie Hurwitz for their recent publication
From bud to stem: dynamics of hematopoietic stem cells that drive homing and mobilization
Link to Publication ▸
|
| |
Congratulations to Reuben Kapur for their recent publication
Inflammatory Bowel Disease-induced Inflammation Augments Clonal Hematopoiesis of Indeterminate Potential through Ref-1
Link to Publication ▸
|
| |
Congratulations to Marie-Dominique Filippi for their recent publication
Activation of a branched-chain amino acid rheostat restores replication-dependent hematopoietic stem cell fitness
Link to Publication ▸
|
| |
|
CIHD Seminar Series: Dr. Meenakshi Banerjee (Utah)
|
| |
|
"Preserving Stemness: Targeting Interferon-Sensitive Genes to Mitigate Inflammatory Hematopoietic Stress"
|
| |
|